Hypofractionated Radiation Therapy for Patients With Breast Cancer Receiving Regional Nodal Irradiation
Sponsor: University of Kansas Medical Center
This NA trial investigates Breast Cancer and is currently ongoing. University of Kansas Medical Center leads this study, which shows 11 recorded versions since 2017 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
May 2021 — Jul 2024 [monthly]
Recruiting NA
-
Jan 2021 — May 2021 [monthly]
Recruiting NA
-
Apr 2020 — Jan 2021 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Feb 2020 — Apr 2020 [monthly]
Recruiting NA
-
Dec 2019 — Feb 2020 [monthly]
Recruiting NA
-
Apr 2019 — Dec 2019 [monthly]
Recruiting NA
-
Jun 2018 — Apr 2019 [monthly]
Recruiting NA
-
Dec 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting · Phase: PHASE2 → NA
-
Jan 2017 — Dec 2017 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Kansas Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .